Clinical effects associated with five-year retinal nerve fiber layer thinning in multiple sclerosis

Association of Spectral-Domain OCT With Long-term Disability Worsening in Multiple Sclerosis

(2021) Jeffrey Lambe et al.   NEUROLOGY

MS optic neuritis-induced long-term structural changes within the visual pathway

(2020) Marc Pawlitzki et al.   Neurology-Neuroimmunology & Neuroinflammation

Progressive Multiple Sclerosis Is Associated with Faster and Specific Retinal Layer Atrophy

(2020) Elias S. Sotirchos et al.   ANNALS OF NEUROLOGY

Serum neurofilament light chain and optical coherence tomography measures in MS

(2020) Eleonora Tavazzi et al.   Neurology-Neuroimmunology & Neuroinflammation

Initial high-efficacy disease-modifying therapy in multiple sclerosis: A nationwide cohort study

(2020) Mathias Due Buron et al.   NEUROLOGY

Optical coherence tomography outcomes from SPRINT-MS, a multicenter, randomized, double-blind trial of ibudilast in progressive multiple sclerosis

(2020) Robert A Bermel et al.   Multiple Sclerosis Journal

Peripapillary retinal nerve fibre layer thinning rate as a biomarker discriminating stable and progressing relapsing remitting multiple sclerosis

(2019) Gabriel Bsteh et al.   EUROPEAN JOURNAL OF NEUROLOGY

Retinal measurements predict 10-year disability in multiple sclerosis

(2019) Alissa Rothman et al.   Annals of Clinical and Translational Neurology

Epidemiology and treatment of multiple sclerosis in elderly populations

(2019) Caila B. Vaughn et al.   Nature Reviews Neurology

Serum neurofilament light chain level associations with clinical and cognitive performance in multiple sclerosis: A longitudinal retrospective 5-year study

(2019) Dejan Jakimovski et al.   Multiple Sclerosis Journal

Multiple sclerosis

(2018) Alan J Thompson et al.   LANCET

Longitudinal study of retinal nerve fiber layer thickness changes in a multiple sclerosis patients cohort: A long term 5 year follow-up

(2018) JM. Abalo-Lojo et al.   Multiple Sclerosis and Related Disorders

Walking disability measures in multiple sclerosis patients: Correlations with MRI-derived global and microstructural damage

(2018) Dejan Jakimovski et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Optical coherence tomography: A quantitative tool to measure neurodegeneration and facilitate testing of novel treatments for tissue protection in multiple sclerosis

(2017) Eliza Gordon-Lipkin et al.   JOURNAL OF NEUROIMMUNOLOGY

Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis

(2017) Axel Petzold et al.   LANCET NEUROLOGY

Longitudinal optical coherence tomography study of optic atrophy in secondary progressive multiple sclerosis: Results from a clinical trial cohort

(2017) Kimberly M Winges et al.   Multiple Sclerosis Journal

Disease-modifying therapies modulate retinal atrophy in multiple sclerosis

(2017) Julia Button et al.   NEUROLOGY

No evidence of disease activity is associated with reduced rate of axonal retinal atrophy in MS

(2017) Marco Pisa et al.   NEUROLOGY

Longitudinal optical coherence tomography study of optic atrophy in secondary progressive multiple sclerosis: Results from a clinical trial cohort

(2017) Kimberly M Winges et al.   Multiple Sclerosis Journal

Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine

(2016) Robert Zivadinov et al.   Expert Review of Neurotherapeutics

Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study

(2016) Lisanne J. Balk et al.   JOURNAL OF NEUROLOGY

Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study

(2016) Elena H Martinez-Lapiscina et al.   LANCET NEUROLOGY

The APOSTEL recommendations for reporting quantitative optical coherence tomography studies

(2016) Andrés Cruz-Herranz et al.   NEUROLOGY

Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine

(2016) Robert Zivadinov et al.   Expert Review of Neurotherapeutics

Optical coherence tomography reflects brain atrophy in multiple sclerosis: A four-year study

(2015) Shiv Saidha et al.   ANNALS OF NEUROLOGY

Retinal nerve fibre layer thickness floor and corresponding functional loss in glaucoma

(2014) Jean-Claude Mwanza et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Retinal nerve fiber layer thickness and thalamus pathology in multiple sclerosis patients

(2014) R. Zivadinov et al.   EUROPEAN JOURNAL OF NEUROLOGY

Disease course heterogeneity and OCT in multiple sclerosis

(2014) LJ Balk et al.   Multiple Sclerosis Journal

Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria

(2014) S Schippling et al.   Multiple Sclerosis Journal

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial

(2012) Jeffrey A Cohen et al.   LANCET

Effect of optic neuritis on progressive axonal damage in multiple sclerosis patients

(2011) E Garcia-Martin et al.   Multiple Sclerosis Journal

Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosis

(2007) Erica Grazioli et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES